Oncology· 2015Q2
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
- 1,941citations
- Q2SCImago
- 2015year
Short summary
Lynch syndrome mutations were found at similar rates in patients diagnosed with colorectal cancer between ages 50-59 as in those diagnosed before 50, suggesting current age-based guidelines under-identify at-risk individuals.
AI-generated from the title and abstract; the full text is not read.
Key points
- Lynch syndrome (LS) genetic testing guidelines may under-identify at-risk patients.
- Deleterious MMR mutation rates were similar in colorectal cancer patients diagnosed at ages 50-59 vs. <50 years.
- This similarity held true even for patients with limited family history suggestive of LS.
- Age at diagnosis is an insufficiently sensitive predictor for hereditary cancer susceptibility.
AI-generated from the title and abstract; the full text is not read.
Abstract
OBJECTIVE: Patients diagnosed with colorectal cancer before the age of 50 years are recommended for Lynch syndrome (LS) testing according to current clinical guidelines. However, many patients are not identified because of the stringent guidelines on existing diagnostic criteria. The aim of this analysis was to evaluate the ability of existing criteria to adequately ascertain patients appropriate for LS genetic testing. METHOD: To determine whether existing clinical diagnostic criteria underascertain individuals who would be appropriate candidates for hereditary cancer risk assessment, we stratified the detection rate of deleterious mismatch repair (MMR) mutations in 9,109 patients with a personal history of colorectal cancer who were diagnosed between the ages of 30 and 74 years with little or no family history suggestive of LS by 5-year age-at-detection intervals. RESULTS: There was little difference in the aggregate positive mutation rate in individuals diagnosed between the ages of 50 and 59 years compared to the positive mutation rate in patients diagnosed before the age of 50 years. CONCLUSION: These results suggest that cancer diagnosis under the age of 50 years is an insufficiently sensitive predictor of hereditary cancer susceptibility.
The authors' abstract, as published at the source. Oncology, 2015 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pathology and Forensic Medicine
Pathology and Forensic MedicineMedicine